IL220513A0 - Pharmaceutical composition comprising vitamin d analogue and cosolvent-surfactant mixture - Google Patents

Pharmaceutical composition comprising vitamin d analogue and cosolvent-surfactant mixture

Info

Publication number
IL220513A0
IL220513A0 IL220513A IL22051312A IL220513A0 IL 220513 A0 IL220513 A0 IL 220513A0 IL 220513 A IL220513 A IL 220513A IL 22051312 A IL22051312 A IL 22051312A IL 220513 A0 IL220513 A0 IL 220513A0
Authority
IL
Israel
Prior art keywords
cosolvent
analogue
vitamin
pharmaceutical composition
surfactant mixture
Prior art date
Application number
IL220513A
Other versions
IL220513A (en
Original Assignee
Leo Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharma As filed Critical Leo Pharma As
Publication of IL220513A0 publication Critical patent/IL220513A0/en
Publication of IL220513A publication Critical patent/IL220513A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/113Multiple emulsions, e.g. oil-in-water-in-oil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/08Antiseborrheics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL220513A 2009-12-22 2012-06-19 Composition for cutaneous application comprising calcipotriol and use thereof IL220513A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/DK2009/000266 WO2011076206A1 (en) 2009-12-22 2009-12-22 Pharmaceutical composition comprising vitamin d analogue and cosolvent-surfactant mixture

Publications (2)

Publication Number Publication Date
IL220513A0 true IL220513A0 (en) 2012-08-30
IL220513A IL220513A (en) 2016-05-31

Family

ID=44194970

Family Applications (1)

Application Number Title Priority Date Filing Date
IL220513A IL220513A (en) 2009-12-22 2012-06-19 Composition for cutaneous application comprising calcipotriol and use thereof

Country Status (13)

Country Link
EP (1) EP2515912A4 (en)
JP (1) JP5548275B2 (en)
CN (1) CN102770143B (en)
AU (1) AU2009357263B2 (en)
BR (1) BR112012015447A2 (en)
CA (1) CA2785249A1 (en)
HK (1) HK1177695A1 (en)
IL (1) IL220513A (en)
MX (1) MX2012007227A (en)
NZ (1) NZ601002A (en)
RU (1) RU2500387C1 (en)
WO (1) WO2011076206A1 (en)
ZA (1) ZA201204619B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107643354B (en) * 2016-07-22 2022-02-01 重庆华邦胜凯制药有限公司 Separation and determination method of calcipotriol starting material A and related impurities
CN106265511A (en) * 2016-08-22 2017-01-04 江苏知原药业有限公司 A kind of calcipotriol betamethasone self-micro emulsion formulation of excellent performance
CN106265485A (en) * 2016-08-22 2017-01-04 江苏知原药业有限公司 A kind of calcipotriol compositions of improved stability
CN106344589B (en) * 2016-11-10 2019-11-26 江苏知原药业有限公司 A kind of Calcipotriol betamethasone composition of improved stability
CN108904445A (en) * 2018-08-06 2018-11-30 江苏知原药业有限公司 Its salts nano suspending liquid
US20230225970A1 (en) * 2020-08-26 2023-07-20 Canadian Nano Pharmaceutical Technology Inc. Nano-Emulsion Based Compositions, Methods for Their Preparation and Their Use in Delivery of Active Ingredients
CN115350151B (en) * 2022-09-29 2023-09-12 湖北欣泽霏药业有限公司 High-stability alfacalcidol liquid oral preparation and preparation method thereof
CN116473985A (en) * 2023-03-29 2023-07-25 暨南大学 Polyene antifungal pharmaceutical composition and application thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39706E1 (en) * 1993-01-15 2007-06-26 Leo Pharma A/S Crystalline form of a vitamin D analogue
JP3340310B2 (en) * 1996-03-28 2002-11-05 株式会社資生堂 Composite emulsion and method for producing the same
US6432422B1 (en) * 1997-12-09 2002-08-13 Chugai Seiyaku Kabushiki Kaisha Creams containing vitamin D3 derivatives
CA2312060A1 (en) * 1997-12-09 1999-06-17 Chugai Seiyaku Kabushiki Kaisha Lotions containing vitamin d3 derivatives
US5990100A (en) * 1998-03-24 1999-11-23 Panda Pharmaceuticals, L.L.C. Composition and method for treatment of psoriasis
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
PT1178960E (en) * 1999-04-23 2004-03-31 Leo Pharma As VITAMIN D ANALOGS AND THEIR PHARMACEUTICAL UTILIZATION
JP2001025359A (en) * 1999-07-15 2001-01-30 Mitsubishi-Kagaku Foods Corp O/w/o type emulsion composition and its production
EP1901709A2 (en) * 2005-06-10 2008-03-26 Galderma S.A. Controlled release of a drug through skin on the basis of a topical composition comprising a drug, a film-forming silicone and at least one volatile solvent
WO2006138056A1 (en) * 2005-06-15 2006-12-28 Apollo Pharmaceutical, Inc. Pharmaceutical composition comprising a mahonia aquifolium extract for the treatment of psoriasis
FR2893847B1 (en) * 2005-11-30 2010-10-29 Galderma Sa SPRAY COMPOSITION COMPRISING VITAMIN D DERIVATIVE AND OILY PHASE
JP4913487B2 (en) * 2006-07-07 2012-04-11 ポーラ化成工業株式会社 Cosmetics characterized by a feeling of use
FR2909284B1 (en) * 2006-11-30 2012-09-21 Galderma Sa NOVEL VASELIN-FREE OINTMENTAL COMPOSITIONS COMPRISING VITAMIN D DERIVATIVE AND POSSIBLY STEROID ANTI-INFLAMMATORY
FR2911781B1 (en) * 2007-01-26 2009-03-20 Fabre Pierre Dermo Cosmetique DERMATOLOGICAL EMULSION AND PREPARATION METHOD
US10265265B2 (en) * 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP1970049A1 (en) * 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Polyaphron topical composition with vitamin D and corticosteroid

Also Published As

Publication number Publication date
CN102770143B (en) 2014-11-05
ZA201204619B (en) 2013-09-25
AU2009357263A1 (en) 2012-07-19
CN102770143A (en) 2012-11-07
NZ601002A (en) 2014-09-26
HK1177695A1 (en) 2013-08-30
IL220513A (en) 2016-05-31
RU2500387C1 (en) 2013-12-10
AU2009357263B2 (en) 2015-04-09
EP2515912A1 (en) 2012-10-31
WO2011076206A1 (en) 2011-06-30
EP2515912A4 (en) 2013-12-25
JP2013515017A (en) 2013-05-02
JP5548275B2 (en) 2014-07-16
BR112012015447A2 (en) 2016-03-15
MX2012007227A (en) 2012-07-30
CA2785249A1 (en) 2011-06-30

Similar Documents

Publication Publication Date Title
IL275854A (en) Pharmaceutical composition and administration thereof
HK1250313A1 (en) Stable pharmaceutical composition and methods of using same
IL253870B (en) Certain amino-pyrimidines and pharmaceutical compositions comprising them
IL247260A0 (en) A pharmaceutical spray composition comprising a vitamin d analogue and a corticosteroid
IL217912A (en) 5-amino-1- benzimidazole-pyrazole derivatives and pharmaceutical compositions comprising them
ZA201200722B (en) Pharmaceutical composition and administrations thereof
IL215497A0 (en) Oxadiazile derivatives and pharmaceutical compositions containing them
ZA201100605B (en) Micronised progesterone pharmaceutical composition and uses thereof
HK1177695A1 (en) Pharmaceutical composition comprising vitamin d analogue and cosolvent- surfactant mixture d-
PT2474522E (en) Agomelatine and pharmaceutical compositions thereof
IL206594A (en) Azinone-tetrahydropyridoindole derivatives and pharmaceutical compositions comprising thereof
ZA201200079B (en) Pharmaceutical compositions and solid forms
HK1177696A1 (en) Pharmaceutical composition comprising solvent mixture and a vitamin derivative or analogue
GB0902648D0 (en) Pharmaceutical compounds and compositions
IL219018A (en) Pharmaceutical compositions of radezolid and uses thereof
GB0908317D0 (en) Pharmaceutical compounds and compositions
GB0919055D0 (en) Pharmaceutical compounds and compositions
GB0902651D0 (en) Pharmaceutical compounds and compositions
GB0903945D0 (en) Pharmaceutical compounds and compositions
GB0908069D0 (en) Pharmaceutical compounds and compositions

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees